NZ331105A - Inhibiting colon tumors using benzothiophene derivatives - Google Patents

Inhibiting colon tumors using benzothiophene derivatives

Info

Publication number
NZ331105A
NZ331105A NZ331105A NZ33110597A NZ331105A NZ 331105 A NZ331105 A NZ 331105A NZ 331105 A NZ331105 A NZ 331105A NZ 33110597 A NZ33110597 A NZ 33110597A NZ 331105 A NZ331105 A NZ 331105A
Authority
NZ
New Zealand
Prior art keywords
compound
cell
control
cells
mol
Prior art date
Application number
NZ331105A
Other languages
English (en)
Inventor
Maria Luisa Brandi
Francesco Tonelli
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9603150.5A external-priority patent/GB9603150D0/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NZ331105A publication Critical patent/NZ331105A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
NZ331105A 1996-01-29 1997-01-27 Inhibiting colon tumors using benzothiophene derivatives NZ331105A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1077296P 1996-01-29 1996-01-29
GBGB9603150.5A GB9603150D0 (en) 1996-02-15 1996-02-15 Methods of inhibiting colon tumors
PCT/US1997/002286 WO1997026877A1 (en) 1996-01-29 1997-01-27 Methods of inhibiting colon tumors

Publications (1)

Publication Number Publication Date
NZ331105A true NZ331105A (en) 2000-06-23

Family

ID=26308709

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ331105A NZ331105A (en) 1996-01-29 1997-01-27 Inhibiting colon tumors using benzothiophene derivatives

Country Status (19)

Country Link
EP (1) EP0921799A4 (es)
JP (1) JP2000503994A (es)
KR (1) KR19990082054A (es)
CN (1) CN1209745A (es)
AR (1) AR010978A1 (es)
AU (1) AU707892B2 (es)
BR (1) BR9700778A (es)
CO (1) CO4761062A1 (es)
CZ (1) CZ235498A3 (es)
EA (1) EA001104B1 (es)
ID (1) ID15917A (es)
IL (1) IL125521A (es)
MX (1) MX9806036A (es)
NO (1) NO983451D0 (es)
NZ (1) NZ331105A (es)
PL (1) PL328147A1 (es)
TW (1) TW446560B (es)
WO (1) WO1997026877A1 (es)
YU (1) YU2397A (es)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW366342B (en) * 1992-07-28 1999-08-11 Lilly Co Eli The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
HUT71237A (en) * 1993-10-15 1995-11-28 Lilly Co Eli Pharmaceutical compositions for treating resistant neoplasms containing 2-phenyl-3-aroil-benzotiophene derivatives and process for their preparation
US5574047A (en) * 1993-12-21 1996-11-12 Eli Lilly And Company Methods of inhibiting imperfect tissue repair

Also Published As

Publication number Publication date
NO983451L (no) 1998-07-27
CO4761062A1 (es) 1999-04-27
IL125521A (en) 2001-11-25
IL125521A0 (en) 1999-03-12
AR010978A1 (es) 2000-08-02
AU707892B2 (en) 1999-07-22
MX9806036A (es) 1998-11-29
JP2000503994A (ja) 2000-04-04
CZ235498A3 (cs) 1999-02-17
EP0921799A4 (en) 2002-03-13
EA199800677A1 (ru) 1999-02-25
PL328147A1 (en) 1999-01-18
YU2397A (en) 1999-11-22
WO1997026877A1 (en) 1997-07-31
EP0921799A1 (en) 1999-06-16
KR19990082054A (ko) 1999-11-15
CN1209745A (zh) 1999-03-03
EA001104B1 (ru) 2000-10-30
BR9700778A (pt) 1998-10-06
AU2123997A (en) 1997-08-20
TW446560B (en) 2001-07-21
NO983451D0 (no) 1998-07-27
ID15917A (id) 1997-08-21

Similar Documents

Publication Publication Date Title
US6274601B1 (en) Methods of inhibiting ulcerative mucositis
US5604248A (en) Method for minimizing the uterotrophic effect of tamoxifen and tamoxifen analogs
EP0652004B1 (en) Methods for treating resistant neoplasms
NZ270168A (en) Use of benzothiophene derivatives in the preparation of medicaments for inhibiting post-menopausal syndrome
AU701701B2 (en) Methods of inhibiting breast disorders
CA2138459A1 (en) Methods of inhibiting cns problems in post-menopausal women
US5451590A (en) Methods of inhibiting sexual precocity
US5843974A (en) Methods of inhibiting melanoma using Benzothiophenes as cytotoxic agents per se
MXPA97009466A (es) Medicamento para inhibir el melanoma
AU707892B2 (en) Methods of inhibiting colon tumors
US5670523A (en) Methods of inhibiting musculoaponeurotic fibromatoses (desmoid tumors)
AU707675B2 (en) Methods of inhibiting musculoaponeurotic fibromatoses (desmoid tumors)
NZ292017A (en) Use of raloxifene to treat endometrial cancer
CA2244112A1 (en) Methods of inhibiting colon tumors
CA2170480A1 (en) Methods of inhibiting estrogen positive tumors of the brain or cns
EP0729755A2 (en) 2-Phenyl-3-aroylbenziothiophenen for inhibiting ovarian cancer
CA2244247A1 (en) Methods of inhibiting musculoaponeurotic fibromatoses (desmoid tumors)